+39 02 610346.1 - info@newron.com

Latest press releases

  • 26Jul
    Newron to re-submit US NDA for Xadago® (safinamide) - no additional evaluation of abuse liability or dependence/withdrawal effects required


  • 21Jul
    Newron Pharmaceuticals Announces Initiation of the STARS Study in the United States

         video testimonial

  • 6Jul
    Zambon Launches Xadago® (Safinamide) In The Netherlands For Patients With Mid- To Late-Stage Parkinson’s Disease


  • 27Jun
    Newron to Evaluate Burden of Disease for Rett Syndrome Patients and Families


  • 16Jun
    Newron Pharmaceuticals to Present STARS Trial Design at US Rett Syndrome Symposium


  • 25May
    Newron Pharmaceuticals to Present at the Jefferies 2016 Healthcare Conference in New York

View All

Newron share price


  • 29Nov
    28th Annual Piper Jaffray Healthcare Conference

    November 29 and 30, 2016 - The Lotte New York Palace, New York - USA

  • 21Sep
    Investora Zürich 2016

    September 20 -21, 2016 - ConventionPoint SIX Swiss Exchange, Zürich - Switzerland

  • 23Aug
    Bellevue Healthcare Day

    August 23, 2016 - Marriott Hotel, Zurich, Switzerland

View Event Calendar